A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

Med Sci Monit. 2024 Jan 28:30:e943912. doi: 10.12659/MSM.943912.

Abstract

The clinical association of purpura, arthralgia, and arthritis was first described in 1837 in a publication by Johann Lukas Schönlein, a German physician. In 1874, Eduard Henoch, a student of Schönlein, reported cases of children with purpura, abdominal pain, bloody diarrhea, and joint pain. IgA vasculitis, or Henoch-Schönlein purpura, is a systemic hypersensitivity vasculitis caused by the deposition of immune complexes in small blood vessels, including the renal glomeruli and mesangium. In the skin, the presentation is with non-thrombocytopenic purpura or urticaria. Worldwide, IgA nephropathy is the most common cause of primary glomerulonephritis. Detection of IgA deposition in small blood vessels and the renal glomeruli is diagnostic in most cases. This article aims to review the history, current classification, epidemiology, presentation, and diagnosis of IgA vasculitis and nephropathy, disease associations or trigger factors, including infections, vaccines, and therapeutic agents, and highlights some future approaches to improve diagnosis and clinical management.

Publication types

  • Review

MeSH terms

  • Child
  • Glomerulonephritis, IGA* / complications
  • Glomerulonephritis, IGA* / diagnosis
  • Humans
  • Hypersensitivity*
  • IgA Vasculitis* / diagnosis
  • IgA Vasculitis* / drug therapy
  • Immunoglobulin A / therapeutic use
  • Kidney Glomerulus
  • Vasculitis* / diagnosis

Substances

  • Immunoglobulin A